The Painful Truth

Author of The Painful Truth

Follow Us on FacebookFollow Us on Google+Follow Us on TwitterFollow Us on LinkedInFollow Us on PinterestFollow Us on YouTube
  • Home
  • About
  • Book
  • News
  • Documentary
  • Blog
  • Podcasts
  • Media Room
  • Contact
 RSS

Subscribe to the blog

Poll

What is the greatest priority for changing the way we treat addiction?

View Results

Loading ... Loading ...

Recent Posts

  • Treating Babies with Neonatal Abstinence Syndrome
  • Rare Diseases and Orphan Drugs
  • Marijuana and Pain
  • Virtual Reality Therapy for People in Chronic Pain
  • Breaking Bad 2018
  • Response to People in Pain
  • Everything Isn’t as Perfect as It Seems in Ireland
  • Yes, Restrictions on Opioids Are a Threat to Human Rights
  • David C. Holzman Shatters Addiction Myths
  • Opioid Lawsuits Threaten Lives of Pain Sufferers
  • Utah Opioid Crisis Summit
  • Repeating the Mistakes of the Past
  • Prescription Drug Advertisements
  • Family of Pain
  • The ACPA Presents Programs for Migraine Sufferers

Recent Comments

  • Kenneth R. McClelland on Why Keep a Pain Journal
  • Jim Gibson on Marijuana and Pain
  • John D. Waldron on Breaking Bad 2018
  • Deborah Scheers on Suicide and Chronic Pain
  • Shonya on Response to People in Pain

Archives

  • June 2018 (5)
  • May 2018 (4)
  • April 2018 (4)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (4)
  • December 2017 (5)
  • November 2017 (4)
  • October 2017 (4)
  • September 2017 (5)
  • August 2017 (4)
  • July 2017 (5)
  • June 2017 (4)
  • May 2017 (4)
  • April 2017 (5)
  • March 2017 (4)
  • February 2017 (4)
  • January 2017 (4)
  • December 2016 (5)
  • November 2016 (4)
  • October 2016 (6)
  • September 2016 (6)
  • August 2016 (7)
  • July 2016 (9)
  • June 2016 (8)
  • May 2016 (8)
  • April 2016 (7)
  • March 2016 (10)
  • February 2016 (12)
  • January 2016 (9)
  • December 2015 (6)
  • November 2015 (3)
  • October 2015 (3)
  • September 2015 (2)
  • August 2015 (4)
  • July 2015 (5)
  • June 2015 (5)
  • May 2015 (2)

Breaking Bad 2018

Breaking Bad 2018 by Lynn R. Webster @LynnRWebsterMD

TV’s Hit Show “Breaking Bad” Glamorized Meth Abuse

The television hit show, Breaking Bad, lionized the idea of making and selling meth. A high school teacher who was dying of lung cancer wanted to leave his family enough funds to live, and he chose drug dealing as a way to achieve his goal. The show ran during the 2008-2013 TV seasons and was regarded by some as the greatest television show of all time.

Continue Reading...

Black Box Warnings

Black Box Warnings by Lynn R. Webster @LynnRWebsterMD

 

How Drugs Receive FDA Approval

The Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) is the watchdog agency that’s responsible for testing new medications before they are approved. Drug manufacturers seek approval from the FDA after they have conducted numerous clinical trials and submitted all of their data to the FDA for review. Drugs are approved only if the FDA believes the data supports the efficacy for the targeted indication and that the drugs’ risks are reasonable and manageable.

Continue Reading...

Please Send the FDA Your Comments

Please Send the FDA Your Comments  by Lynn R. Webster @LynnRWebsterMD

New Opioid Policy Steering Committee

On September 29 of this year, the Food and Drug Administration (FDA) published a notice — Opioid Policy Steering Committee; Establishment of a Public Docket; Request for Comments — in the Federal Register, The Daily Journal of the United States Government.

The FDA is seeking comments from members of the public, including chronic pain patients and their families, healthcare professionals, academic institutions, and industry relative to the FDA’s new Opioid Policy Steering Committee (OPSC).

FDA Commissioner Scott Gottlieb, M.D. has expressed his commitment to confronting the opioid crisis and reducing the possibility of opioid addiction. He established the OPSC, and charged the committee with seeking input from the public.

Continue Reading...

The Other Side of the Pain Story by guest Richard L. Martin

The Other Side of the Pain Story

By Richard L. Martin, BSPharm (retired)

The Other Side of the Pain Story, Lynn R Webster, MD @LynnRWebsterMD

I was a hospital pharmacist for twenty-five years. The last four years in practice, I was involved with the cancer ward helping oncologists, recommending pain medications, adjusting pain medications, and safely switching patients from one medication to another. Even though it’s been some fifteen years since I worked in the hospital, I still have at least a rudimentary knowledge of prescription pain management. I am now sixty-four years old.

Continue Reading...

Preparing for an FDA Advisory Committee Meeting: What You Need to Know

Preparing for an FDA Advisory Committee Meeting: What You Need to Know , Lynn R Webster, @LynnRWebsterMD

Mark Twain is quoted as saying: “If I had more time, I would have written a shorter letter.”

What Is an FDA ADCOM?

Pharma and device companies seeking approval for their products are often required to present their data to an FDA advisory committee meeting (ADCOM). They have a limited time in which to tell their story. Therefore, Pharma must know how to “write the short letter.” This requires them to condense years of research into messages that can convey the most salient, and most pertinent, data to a jury of scientists.

Continue Reading...

Here Are the Important Questions We Need to Ask About Prince’s Fentanyl Overdose

Here are the Important Questions We Need To Ask About Prince's Fentanyl Overdose

You’ve probably heard by now that a medical examiner has determined Prince, the musical superstar, died of a fentanyl overdose.

While other opioids get more attention, fentanyl is the stealth bomb for abusers.

Fact About Fentanyl

Fentanyl is 100 times more dangerous than morphine. The dose at which fentanyl produces the pain relief that users require, and the euphoria that drug abusers seek, occurs quickly and at low doses.

However, the dose required to stop a person’s breathing is only a little bit more than the amount users need to get relief from their pain or to get high.

Continue Reading...

Reasons Former FDA Commissioner David Kessler Misses Point of the Opioid Crisis

Reasons Former FDA Commissioner David Kessler Misses Point of the Opioids Crisis

Dr. David A. Kessler was interviewed by Jim Axelrod of CBS News about the opioid crisis. Specifically, Axelrod asked Kessler about the increased use of opioids over the past twenty years, and how we might get the opioid epidemic “back in the bottle.”

Always controversial, since the days between 1990 and 1997 when he served as the Commissioner of the FDA, Kessler calls the handling of opioids “one of the greatest mistakes of modern medicine.”

He blames the opioid epidemic on his former agency, the FDA; pharmaceutical companies; and physicians. “They didn’t see these drugs for what they truly are,” Kessler asserts.

Continue Reading...

Abuse-Deterrent Formulations Are Part of the Solution to Overdose Crisis

 

Abuse-Deterrent Formulations Are Part of the Solution to Overdose Crisis, Lynn R Webster, MD, pain management, opioid crisis

Curbing The Epidemic of Drug Overdoses

Dr. Robert Califf, the new commissioner of the Food and Drug Administration, is focusing his energy on curbing the epidemic of drug overdoses. He told a panel of FDA advisors last week that abuse-deterrent formulations (ADFs) may be part of the solution.

However, many speakers at that panel warned the FDA that it would be a mistake to rely on ADFs to solve the problem.

The advisors are correct. Abuse deterrent formulations (ADFs) are not a magical cure to the problem of opioid abuse.

Continue Reading...

Copyright © 2021 Lynn R. Webster, M.D. | [email protected]